2[3]Decco ML, Neeno TA , Hunt LW, et al ..Veublized lidocaine in the treatment of severe asthma in children:a pilot study [J].Ann Allergy Asthma Immunol. 1999 ,82 (1) ∶29-32.
3[4]Groeben H, Silvanns MT, Beste M, et al . .Both intravenous and inhaled lidocaine attenuate reflex bronchoconstriction but at different plasma concentrations [J]. Am J Respir Cirt Care Med,1999 ,159(2) ∶530-535.
4[6]Khatri SB,Erzurum SC. Alternative therapies for corticosteroid7 dependent asthma Clinical Pulmonary Medicine ,1999 ,6 :271-277.
5[9]Christian Virchow J ,Prasse A, Naya I ,et al. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids [J]. Am J Respir Crit Care Med,2000 ,162 ∶578-585.
6[10]Ihaku D, Cameron L, Suzuki M,et al . Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen,airwa eosinophilia, and IL-5 expressing cells in brown norway rats[J] . J Allerg Clin Immuno1,1999,104∶1147-1154.
7[12]Bisgaard H .Pathophysiolgy of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists asthma[J]. Allergy,2001,56 ∶7-11.
8[13]Sumita B,Khartri MD,Serpil C. Erzurum,MD. Alternative Therapies for Corticosteroid Dependent Asthma[J] Clin Pul Med,1999,6(5) ∶271-277.
9[14]Rabinovitch N, Gelfand EW, Leung DY. The role of immunoglobulin therapy in allergic diseases[J] . Allergy, 1999 ,54 ∶662-668.
10[15]Spahn JD, Leung DY, Chan MT,et al. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin[J]. J Allergyin Immunol ,1999,103∶471-476.
